Skip to content
★ Sign in to follow
GM

GC Medical Science Corporation Stock: price and insider trades · South Korea

녹십자엠에스

KR·Mcap ₩70.7BHealth Care

1 insider bought €3,306 of shares over the last 90 days, the latest by 김연근, filed 28 Oct 2026.

Insider Decl.
27
Thresholds
n/a
Buy Volume
€28M
19 ops. · all time
Sell Volume
€407,741
1 ops. · all time

Who traded when

BuySale
김연근5 buys
김원기2 buys
엄현2 buys
녹십자1 buy
박선희1 buy
양윤정1 buy

Since the insiders bought

  • Filed 11 Mar 2026 · 244 days ago · €1,225
    -18.9%
    Entry ₩3,615 · Close 03 Nov 2026 ₩2,930
  • Filed 11 Mar 2026 · 244 days ago · €3,967
    -18.9%
    Entry ₩3,615 · Close 03 Nov 2026 ₩2,930
  • Filed 04 Apr 2023 · 1316 days ago · €9.7M
    -13.9%
    Entry ₩4,725 · Close at T+365 ₩4,070

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 15,617 of 26,911 companies
46.7
score / 100
Value
60
Quality
33
FCF yld3.4%
Earn yld5.5%
EV/EBITDA9.7x
ROE-4.0%
Gross mgn14%
Net mgn3.4%
Debt/EBITDA2.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,950
Analyst consensus
·
Income statement
Revenue₩108.4B
Gross profit₩15.2B14% margin
EBITDA₩8.7B8% margin
Net income₩3.7B-2.1% margin
Valuation
Beta0.70
Balance sheet & cash
Market cap₩70.7B
Total debt₩17.5B
Free Cash Flow₩2.3B
Debt / Equity27%
Profitability & ownership
ROE-4.0%
ROA1.5%
% insiders47.0%
% institutions0.1%
Last declaration on 28 October 2026
Declarations29 total
  • Other
    Other(filed)
    0DART
  • ▲
    대표이사Executives(filed)
    €3,306est.0DART
    1,500 sharesShareKRXDART:20261028000026
    Canonical exit: 26 Jan 2027 (T+90)
  • Other
    Other(filed)
    0DART
  • ▲
    대량보유자Executives(filed)
    €76kest.0DART
    45,100 sharesKRXDART:20260701000571
    Canonical exit: 29 Sept 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €5,086est.0DART
    3,000 sharesShareKRXDART:20260630000251
    Canonical exit: 28 Sept 2026 (T+90)
  • ▲
    상무Executives(filed)
    €5,086est.0DART
    3,000 sharesShareKRXDART:20260630000262
    Canonical exit: 28 Sept 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €4,916est.0DART
    2,500 sharesShareKRXDART:20260615000115
    Canonical exit: 13 Sept 2026 (T+90)
  • ▲
    상무Executives
    2M KRW31DART
    600 shares@ ₩3,521.000.0034% mcap100.0% of flowShareKRXDART:20260311003649
    Canonical exit: 7 Jun 2026 (T+90)
  • ▲
    대표이사Executives
    7M KRW42DART
    2,000 shares@ ₩3,419.750.011% mcap100.0% of flowShareKRXDART:20260311003639
    Canonical exit: 7 Jun 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    상무Executives(filed)
    €2,277est.0DART
    1,000 sharesShareKRXDART:20260102000243
    Canonical exit: 2 Apr 2026 (T+90)
  • ▲
    상무Executives(filed)
    €2,537est.0DART
    1,000 sharesShareKRXDART:20251104000058
    Canonical exit: 2 Feb 2026 (T+90)
  • ▲
    상무Executives(filed)
    €2,537est.0DART
    1,000 sharesShareKRXDART:20251104000057
    Canonical exit: 2 Feb 2026 (T+90)
  • ▲
    상무Executives(filed)
    €2,525est.0DART
    1,000 sharesShareKRXDART:20251030000172
    Canonical exit: 28 Jan 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €2,525est.0DART
    1,000 sharesShareKRXDART:20251030000170
    Canonical exit: 28 Jan 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives
    €8.4Mest.0DART
    2,968,088 sharesKRXDART:20241018000344
    Canonical exit: 16 Jan 2025 (T+90)
  • ▲
    상무Executives
    0DART
    ShareKRXDART:20240610000237
    Canonical exit: 8 Sept 2024 (T+90)
  • ▲
    상무Executives
    0DART
    ShareKRXDART:20240510000111
    Canonical exit: 6 Aug 2024 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    €9.7Mest.0DART
    2,968,088 sharesKRXDART:20230404002483
    Canonical exit: 3 Jul 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Related company / holdingExecutives(filed)
    €9.5Mest.0DART
    2,968,088 sharesKRXDART:20230221001494
    Canonical exit: 22 May 2023 (T+90)
  • ▲
    Executives
    53M KRW10DART
    10,000 shares@ ₩5,267.80100.0% of flowShareKRXDART:20230221000351
    Canonical exit: 17 May 2023 (T+90)
  • ▼
    Executives(filed)
    €408kest.0DART
    81,985 sharesKRXDART:20220404002847
  • ●
    Executives
    Executives(filed)
    0DART

25 of 29 declarations

About GC Medical Science Corporation

Four insiders bought between October 30 and November 4, 2025 at 녹십자엠에스 (GC Medical Science Corporation). Across the full history, 2 purchase filings are classed as clustered. Purchases come mostly from executives: 김연근 (대표이사) and 엄현 (상무) each have 4 filings, all purchases, of EUR 3,967 and EUR 1,225 respectively on March 9, 2026. The largest purchase with an amount, EUR 38,350, is by 사공영희 on February 16, 2023. This South Korean health care company, valued at KRW 96.3 billion and 47% held by insiders, counts 18 purchases for 1 sale, or 95% purchases among open-market trades. Three purchases carry an amount, EUR 43,542 in total with a median of EUR 3,967. 타임폴리오자산운용 has 4 purchases, 녹십자 (대량보유자) 1 purchase and 1 sale, and the company 녹십자엠에스 6 filings with neither purchase nor sale. 26 filings were published from March 9, 2021 to July 1, 2026: 8 in 2026, 5 in 2025, 4 in both 2022 and 2023, 3 in 2024, 2 in 2021. The last twelve months gather 12, 11 of them purchases.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations